ORANGE COUNTY

Belgrade Deal Boosts ICN Stock: ICN Pharmaceuticals Inc.’s stock jumped 25% over the past two days on an announcement that its Belgrade subsidiary has obtained approval to import raw materials into the war-torn region that was Yugoslavia. The Costa Mesa company’s stock, which had been languishing in the $10 range, jumped $1.37 a share Friday on the New York Stock Exchange, to close at $11.75 a share. ICN’s chief subsidiary, SPI Pharmaceuticals Inc. has a 75% stake in ICN Galenika, based in Belgrade. The company has suffered financially because of the inability of ICN Galenika to obtain raw materials for drug manufacturing.